Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Kinase inhibitor GW8510 rejuvenates yeast and mice through multiple pathways including SRC, PAKs, JAKs

ABSTRACT: Kinase inhibitor GW8510 rejuvenates yeast and mice through multiple pathways including SRC, PAKs, JAKs

PROVIDER: PRJNA894130 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR22033085_1.fastq.gz	Fastqsanger.gz
	SRR22033085_2.fastq.gz	Fastqsanger.gz
	SRR22033086_1.fastq.gz	Fastqsanger.gz
	SRR22033086_2.fastq.gz	Fastqsanger.gz
	SRR22033087_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 30

Similar Datasets

Kinase inhibitor GW8510 rejuvenates yeast and mice through multiple pathways including SRC, PAKs, JAKs

Project description:Aging, a risk factor for many diseases, is largely attributable to cell senescence and impaired mitochondrial function. Here, we used connectivity map (CMAP) to predict the anti-aging effects of drugs based on age-related transcriptomic signatures. We found the kinase inhibitor GW8510 can extend lifespan of yeast, and C57BL/6J or ICR mice by 92.18%, 31.9%, and 142.9%, respectively. Mechanistically, GW8510 can ameliorate cellular senescence by enhancing mitochondrial function, decreasing SA-β-gal staining, p21 and SASP marker expression, and rescues age-related histomorphological changes in mouse hippocampus, heart, kidney and liver. In yeast, the action of GW8510 is dependent on STE20, and in human cells, GW8510 acts through various pathways such as SRC, PAKs, and JAKs. Furthermore, inhibiting these genes can delay cellular senescence. This work provides a valuable resource for mechanistic aging studies and suggests strong clinical potential for GW8510.

2023-10-30 | GSE216516 | GEO

The allosteric landscape of the Src kinase

Project description:The allosteric landscape of the Src kinase

| PRJNA1040239 | ENA

The allosteric landscape of the Src kinase

Project description:Enzymes catalyze the reactions of life and are the targets of nearly all small molecule drugs. Most drugs inhibit enzymes by binding to conserved active sites, causing problems of specificity and toxicity. Targeting regulatory allosteric sites can increase specificity, overcome drug resistance and tune or activate activity.However, the vast majority of enzymes have no known allosteric sites and methods do not exist to globally identify or predict them.Here we present a general and fast method to globally chart allosteric communication in enzymes and apply it to the Src protein kinase to produce the first comprehensive map of negative and positive allosteric control of enzymatic activity. Allosteric control of Src is pervasive, anisotropic and distance dependent, but fairly predictable from simple sequence and structural features. The comprehensive allosteric map enables unbiased identification of all the allosterically active surface pockets of the Src kinase for the development of activatory and inhibitory drugs.This general approach can be used to chart global allosteric maps of many kinases, enzymes, and other biochemical activities important for medicine and biotechnology.

2024-04-27 | GSE247740 | GEO

Gene expression during PMA-induced neutrophil NETs formation with or without knockout of neutrophils of Src kinase

Project description:Src kinase has functions in regulating reactive oxygen species production, degranulation, NETs formation, integrin activation, and migration to human infection sites in neutrophils. RNA sequencing was performed by extracting mRNA from PMA-induced mouse neutrophils with or without Src kinase knockout(Src fl/fl S100a8 Cre or Src fl/fl mice). Gene enrichment analysis by Genomes (Reactome) identified RAF/MAP kinase cascade in the top ten significantly changed pathways.

2025-06-01 | GSE251972 | GEO

Phosphosecretome profiling and kinase-substrate interaction screening reveal key extracellular c-Src-regulated pathways

Project description:Secreted protein kinases are responsible for the phosphorylation of a vast number of extracellular phosphoproteins. The tyrosine kinase c-Src is secreted through the vesicular trafficking pathway, however, mechanistic insights into extracellular substrate specificity and potential therapeutic opportunities in cancer remain unexplored. Here, we show that the SH4/Unique region of c-Src is required for its secretion. Limited proteolysis-mass spectrometry together with mutagenesis further confirmed predictions of in-silico molecular docking of active c-Src structure with its bona fide substrate TIMP2, that the Src homology 3 (SH3) domain is critical for kinase interaction with the P31xxP34 motif in the amino domain of TIMP2. Interestingly, comprehensive unbiased phosphoproteomic studies revealed an enrichment of PxxP containing extracellular substrates as potential targets of secreted c-Src. Cell-based studies using custom anti-c-Src antibodies against the c-Src SH3-TIMP2 interacting interface revealed that blocking secreted Src not only disrupts kinase-substrate interaction but also inhibits prostate cancer cell proliferation. Together, our data provide insights into the intricate role of secreted c-Src in extracellular phosphorylation.

2023-05-30 | PXD036069 | Pride

Bead-based kinase phosphorylation profiling identifies SRC as a therapeutic target in glioblastoma

Project description:Here we describe a bead-based method capable of profiling tyrosine kinase phosphorylations in a multiplexed, high-throughput and low-cost manner. This approach allows for the discovery of tyrosine kinase-activating events, even when the DNA sequence is wild-type. In an effort to pilot the establishment of a tyrosine kinase activation catalog, we profiled tyrosine phosphorylation levels of 62 tyrosine kinases in 130 human cancer lines, and followed-up on the frequent SRC phosphorylation in glioblastoma. Keywords: quantitative measurements of tyrosine phosphorylation levels on tyrosine kinases Total protein lysates were collected from 130 cancer cell lines. Tyrosine phosphorylation levels on 62 tyrosine kinases were measured with the bead assay.

2010-06-24 | E-GEOD-13808 | biostudies-arrayexpress

Bead-based kinase phosphorylation profiling identifies SRC as a therapeutic target in glioblastoma

2008-12-05 | GSE13808 | GEO

Molecular determinants of Hsp90 recognition of Src kinase revealed by deep mutational scanning

Project description:Protein tyrosine kinases are involved in regulating growth and proliferation in cells and are often hyperactive in cancerous tissue. Tyrosine kinase inhibitors have been used to limit hyperactivity but become ineffective due to the appearance of resistance mutations. A common trait of hyperactive protein kinases is its strict client relationship with molecular chaperone Hsp90. However, the mechanism behind Hsp90 client kinase recognition is poorly understood. Here we measure the functional effect of thousands of single amino acid variants in the Src kinase domain to identify positions invovled in Hsp90 client recognition.

2023-05-22 | GSE218190 | GEO

Analysis of EYA3 phosphorylation by Src kinase

Project description:Data-dependent nLC-MS/MS analysis of EYA3 phosphorylation by Src protein tyrosine kinase

2019-12-17 | PXD016526 | Pride

Analysis of EYA3 phosphorylation by Src kinase

Project description:Data-dependent nLC-MS/MS analysis of EYA3 phosphorylation by Src protein tyrosine kinase

2019-12-17 | PXD016532 | Pride